| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cellectar Biosciences, Inc. | Chief Commercial Officer | Common Stock | 39,599 | $11,088 | $0.2800 | 08 Dec 2023 | Direct |
| Cellectar Biosciences, Inc. | Chief Commercial Officer | Stock option (right to buy) | 260,000 | 14 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CLRB | Cellectar Biosciences, Inc. | 14 Jun 2024 | 1 | $0 | 4 | Chief Commercial Officer | 18 Jun 2024, 17:02 |
| CLRB | Cellectar Biosciences, Inc. | 23 Jun 2023 | 2 | $0 | 4 | Chief Commercial Officer | 12 Dec 2023, 20:09 |
| CLRB | Cellectar Biosciences, Inc. | 21 Nov 2022 | 1 | $0 | 4 | Chief Commercial Officer | 15 Dec 2022, 16:00 |
| CLRB | Cellectar Biosciences, Inc. | 21 Nov 2022 | 0 | $0 | 3 | Chief Commercial Officer | 15 Dec 2022, 15:45 |